Switch theme
Sign up to access all valuation multiples
NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.
2015
986
LTM Revenue $913M
LTM EBITDA $40.1M
$1.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
NeueHealth has a last 12-month revenue (LTM) of $913M and a last 12-month EBITDA of $40.1M.
In the most recent fiscal year, NeueHealth achieved revenue of $937M and an EBITDA of -$65.1M.
NeueHealth expects next 12-month revenue of XXX and NTM EBITDA of XXX
See NeueHealth valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $913M | XXX | $937M | XXX | XXX | XXX |
| Gross Profit | $913M | XXX | $195M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 21% | XXX | XXX | XXX |
| EBITDA | $40.1M | XXX | -$65.1M | XXX | XXX | XXX |
| EBITDA Margin | 4% | XXX | -7% | XXX | XXX | XXX |
| EBIT | n/a | XXX | -$95.0M | XXX | XXX | XXX |
| EBIT Margin | n/a | XXX | -10% | XXX | XXX | XXX |
| Net Profit | -$99.7M | XXX | -$135M | XXX | XXX | XXX |
| Net Margin | -11% | XXX | -14% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $121M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, NeueHealth's stock price is $7.
NeueHealth has current market cap of $61.3M, and EV of $1.0B.
See NeueHealth trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.0B | $61.3M | XXX | XXX | XXX | XXX | $-13.41 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, NeueHealth has market cap of $61.3M and EV of $1.0B.
NeueHealth's trades at 1.1x EV/Revenue multiple, and -16.0x EV/EBITDA.
Equity research analysts estimate NeueHealth's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
NeueHealth has a P/E ratio of -0.6x.
See valuation multiples for NeueHealth and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $61.3M | XXX | $61.3M | XXX | XXX | XXX |
| EV (current) | $1.0B | XXX | $1.0B | XXX | XXX | XXX |
| EV/Revenue | 1.1x | XXX | 1.1x | XXX | XXX | XXX |
| EV/EBITDA | 26.1x | XXX | -16.0x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -11.0x | XXX | XXX | XXX |
| EV/Gross Profit | 1.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | -0.6x | XXX | -0.5x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -8.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialNeueHealth's last 12 month revenue growth is -2%
NeueHealth's revenue per employee in the last FY averaged $0.9M, while opex per employee averaged $0.3M for the same period.
NeueHealth's rule of 40 is -51% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
NeueHealth's rule of X is 0% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for NeueHealth and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | -2% | XXX | -1% | XXX | XXX | XXX |
| EBITDA Margin | 4% | XXX | -7% | XXX | XXX | XXX |
| EBITDA Growth | 78% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -51% | XXX | -9% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 0% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.9M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 31% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Genesis Fertility Center | XXX | XXX | XXX | XXX | XXX | XXX |
| Dc Healthcare Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Health Italia | XXX | XXX | XXX | XXX | XXX | XXX |
| Alignment Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Clover Health | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
NeueHealth acquired XXX companies to date.
Last acquisition by NeueHealth was XXXXXXXX, XXXXX XXXXX XXXXXX . NeueHealth acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was NeueHealth founded? | NeueHealth was founded in 2015. |
| Where is NeueHealth headquartered? | NeueHealth is headquartered in United States of America. |
| How many employees does NeueHealth have? | As of today, NeueHealth has 986 employees. |
| Who is the CEO of NeueHealth? | NeueHealth's CEO is Mr. G. Mike Mikan. |
| Is NeueHealth publicy listed? | Yes, NeueHealth is a public company listed on NYS. |
| What is the stock symbol of NeueHealth? | NeueHealth trades under NEUE ticker. |
| When did NeueHealth go public? | NeueHealth went public in 2021. |
| Who are competitors of NeueHealth? | Similar companies to NeueHealth include e.g. Genesis Fertility Center, Dc Healthcare Holdings, Health Italia, Alignment Healthcare. |
| What is the current market cap of NeueHealth? | NeueHealth's current market cap is $61.3M |
| What is the current revenue of NeueHealth? | NeueHealth's last 12 months revenue is $913M. |
| What is the current revenue growth of NeueHealth? | NeueHealth revenue growth (NTM/LTM) is -2%. |
| What is the current EV/Revenue multiple of NeueHealth? | Current revenue multiple of NeueHealth is 1.1x. |
| Is NeueHealth profitable? | Yes, NeueHealth is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of NeueHealth? | NeueHealth's last 12 months EBITDA is $40.1M. |
| What is NeueHealth's EBITDA margin? | NeueHealth's last 12 months EBITDA margin is 4%. |
| What is the current EV/EBITDA multiple of NeueHealth? | Current EBITDA multiple of NeueHealth is 26.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
